from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0279c/PE_PGRS4

LFCtreatmentdescriptionclass of inhibitor

0.190

Amikacinug/mL Amikacintranslation

-0.181

Cap5-10ug/mL Capreomycintranslation

0.826

Rox10-50 ug/mL Roxithromycintranslation

-0.168

SM2-5 ug/mL Streptomycintranslation

0.127

Tet5-10 ug/mL Tetracyclinetranslation

-1.759

Rif0.2-5ug/mL Rifampicintranscription

-1.030

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.774

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.063

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.458

CPZ10-50 ug/mL Chlorpromazinerespiration

0.717

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.422

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.490

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.222

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.649

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.593

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.402

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.864

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.190

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.335

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.462

KCN5-20 ug/mL Potassium cyaniderespiration

0.302

NaN30.2-2 mM Sodium aziderespiration

0.163

Nigericin50 uM Nigericinrespiration

0.436

TRC10-150 ug/mL Triclosanrespiration

0.390

TRZ10-25 ug/mL Thioridazinerespiration

3.371

Valinomycin0.5-10 uM Valinomycinrespiration

-1.911

ZnSO42 mM ZnSO4respiration

-0.550

menadione6-10 ug/mL Menadionerespiration

-0.149

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.461

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.316

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.079

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.344

NRP_1Non-replicating persistence stage 1dosRassociated

0.179

Amp0.2mg/mL AmpicillincellWall

-0.536

Cephalexin20-100 ug/mL CephalexincellWall

-0.333

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.319

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.272

EMB10-20 ug/mL EthambutolcellWall

-0.155

Eta12-40 ug/mL EthionamidecellWall

-0.174

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.234

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.183

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.719

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.118

BZA0.12 mg/mL BenzamidearomaticAmides

0.065

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.206

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.183

H2O24 mM hydrogen peroxideDNAdamaging

0.918

Levo10 ug/mL LevofloxacinDNAdamaging

-0.589

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.024

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.321

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.493

UVUV-irradiationDNAdamaging

0.692

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.473

Antimycin12.5-50 ug/mL Antimycin A?

0.017

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.841

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.501

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.570

PA8240.2-2 ug/mL PA-824?

0.206

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.490

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.197

Verapamil50 uM Verapamil?

0.065

mercaptoethanol2 mM 2-Mercaptoethanol?

0.586

methoxatin10-20 ug/mL Methoxatin?